跳轉至內容
Merck
全部照片(1)

重要文件

SML0474

Sigma-Aldrich

(S)-度洛西汀 盐酸盐

≥98% (HPLC)

同義詞:

(γS)-N-甲基-3-(萘-1-基氧)-3-(噻吩-2-基)丙烷-1-胺 盐酸盐, (+)-(S)-N-甲基-γ-(1-萘氧基)-2-噻吩丙胺 盐酸盐, (+)-N-甲基-3-(1-萘氧基)-3-(2-噻吩)-丙胺 盐酸盐, LY-248686 盐酸盐

登入查看組織和合約定價


About This Item

經驗公式(希爾表示法):
C18H19NOS · HCl
CAS號碼:
分子量::
333.88
MDL號碼:
分類程式碼代碼:
12352200
PubChem物質ID:
NACRES:
NA.77

化驗

≥98% (HPLC)

形狀

powder

光學活性

[α]/D +116 to +125°, c = 1 in methanol

儲存條件

desiccated

顏色

white to beige

溶解度

H2O: 5 mg/mL (clear solution, warmed)

儲存溫度

room temp

SMILES 字串

Cl.CNCC[C@H](Oc1cccc2ccccc12)c3cccs3

InChI

1S/C18H19NOS.ClH/c1-19-12-11-17(18-10-5-13-21-18)20-16-9-4-7-14-6-2-3-8-15(14)16;/h2-10,13,17,19H,11-12H2,1H3;1H/t17-;/m0./s1

InChI 密鑰

BFFSMCNJSOPUAY-LMOVPXPDSA-N

基因資訊

尋找類似的產品? 前往 產品比較指南

一般說明

(S)-Duloxetine hydrochloride belongs to the class of serotonin and norepinephrine reuptake inhibitors. Duloxetine is a thiophene derivative. It is used to treat stress urinary incontinence, psychiatric and metabolic disorders. It is also used for treating diabetic peripheral neuropathic pain, fibromyalgia, chronic musculoskeletal and low back pain (LBP). Duloxetine is a cytochrome P450 2D6 (CYP2D6) inhibitor.

應用

(S)-Duloxetine hydrochloride has been used as an antidepressant in rats exposed to chronic mild stress (CMS).

生化/生理作用

盐酸度洛西汀是一种双重血清素/去甲肾上腺素再摄取抑制剂(SNRI),在临床上被广泛用作抗抑郁药和抗焦虑药。
盐酸度洛西汀是一种双重血清素/去甲肾上腺素再摄取抑制剂(SNRI);抗抑郁药;抗焦虑药。

特點和優勢

This compound is featured on the Biogenic Amine Transporters page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here.

注意

air sensitive

象形圖

Exclamation mark

訊號詞

Warning

危險聲明

危險分類

Acute Tox. 4 Oral

儲存類別代碼

11 - Combustible Solids

水污染物質分類(WGK)

WGK 3

閃點(°F)

Not applicable

閃點(°C)

Not applicable


從最近期的版本中選擇一個:

分析證明 (COA)

Lot/Batch Number

未看到正確版本?

如果您需要一個特定的版本,您可以透過批號來尋找特定憑證。

已經擁有該產品?

您可以在文件庫中找到最近購買的產品相關文件。

存取文件庫

客戶也查看了

Slide 1 of 1

1 of 1

High-performance liquid chromatographic method for the simultaneous estimation of the key intermediates of duloxetine
Soni P, et al.
Talanta, 67(5), 975-978 (2005)
A review of duloxetine 60 mg once-daily dosing for the management of diabetic peripheral neuropathic pain, fibromyalgia, and chronic musculoskeletal pain due to chronic osteoarthritis pain and low back pain
Pergolizzi Jr JV, et al.
Pain Practice : The Official Journal of World Institute of Pain, 13(3), 239-252 (2013)
Mechanisms of pain transmission and pharmacologic management
Argoff C
Current Medical Research and Opinion, 27(10), 2019-2031 (2011)
Modulation of the antioxidant nuclear factor (erythroid 2-derived)-like 2 pathway by antidepressants in rats
Martin-Hernandez D, et al.
Neuropharmacology, 103(3), 79-91 (2016)
David Martín-Hernández et al.
Molecular neurobiology, 56(11), 7522-7533 (2019-05-06)
The standard pharmacological treatment of the major depressive disorder (MDD) is still grounded in a monoaminergic approach. Consequently, antidepressant treatments pursue to heighten serotonergic and noradrenergic neurotransmissions. Thus, the aim of this study was to assess the impact of exposure

我們的科學家團隊在所有研究領域都有豐富的經驗,包括生命科學、材料科學、化學合成、色譜、分析等.

聯絡技術服務